Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Sundial vs. Cronos: Which Cannabis Stock is a Better Buy?

Published 07/23/2021, 12:18 PM
Updated 07/23/2021, 01:30 PM
© Reuters.  Sundial vs. Cronos: Which Cannabis Stock is a Better Buy?

Sundial (SNDL) and Cronos Group (NASDAQ:CRON) are two beaten-down cannabis stocks with significant potential. However both the companies need to improve profit margins and reduce cash burn in order to gain investors confidence. Which of these two stocks should you invest in right now?.Canadian cannabis stocks have grossly underperformed the broader markets over the past couple of years. Most of them have been grappling with industry-wide issues, that include the slow rollout of retail chains in major Canadian provinces, competition from a thriving black market as well as overvalued acquisitions.

This in turn led to tepid demand for cannabis products, high inventory levels, widening losses, and multi-billion-dollar goodwill write-downs. Further, in order to offset cash burn, cannabis companies have raised equity capital several times, which has diluted shareholder wealth and contributed to their stock decline.

However, the marijuana market in Canada continues to expand and cannabis legalization efforts around the world makes these stocks compelling bets for long-term growth investors. In this article I’m going to analyze two canadian cannabis stocks, Sundial (SNDL) and Cronos (CRON), to see which is the better buy now.

Continue reading on StockNews

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.